Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 4163-4167

  Skagias, Lazaros ^a   Politi, Ekaterini ^a   Karameris, Andreas ^b   Sambaziotis, Dimitrios ^c   Archondakis, Athanasios ^c   Ntinis, Apostolos ^a   Moreas, Iraklis ^c   Vasou, Olympia ^a   Koutselini, Helen ^a   Patsouris, Efstratios ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b 417 VA Hospital (NIMTS)   (Greece)

^c 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Immunohistochemistry; Recurrence; Survivin; Urothelial carcinoma

Indexed keywords

CYTOPLASM PROTEIN; NUCLEAR PROTEIN; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL TIME; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 71949116471     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A and Ward E: Cancer statistics 2004. CA Cancer J Clin 54: 8-29, 2004.
2. Deveraux QL and Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 13: 239-252, 1999.
3. Blanc-Brude OP, Mesri M, Wall NR et al: Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 9: 2683-2692, 2003. (Pubitemid 36842114)
4. Kawasaki H, Toyoda M, Shinohara H et al: Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91: 2026-2032, 2001. (Pubitemid 32476366)
5. Sarela AI, Macadam RCA, Farmery SM, Markham AF and Guillou PJ: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46: 645-650, 2000.
6. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F et al: Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88: 115-119, 2003. (Pubitemid 36241227)
7. Ikeguchi M, Ueda T, Sakatani T, Hirooka Y and Kaibara N: Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol 11: 33-40, 2002. (Pubitemid 34171210)
8. Monzo M, Rosell R, Felip E et al: A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers. J Clin Oncol 17: 2100-2104, 1999. (Pubitemid 29318841)
9. Athanassiadou P, Grapsa D, Athanassiades P, Gonidi M, Athanassiadou AM, Tsipis A and Patsouris E: The prognostic significance of COX-2 and survivin expression in ovarian cancer. Pathol Res Pract 204(4): 241-249, 2008.
10. Chakravarti A, Noll E, Black PM et al: Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20: 1063-1068, 2002. (Pubitemid 34141851)
11. Mori A, Wada H, Nishimura Y, Okamoto T, Takemoto Y and Kakishita E: Expression of the antiapoptosis gene survivin in human leukemia. Int J Hematol 75: 161-165, 2002. (Pubitemid 43014079)
12. Islam A, Kageyama H, Takada N, et al: High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-623, 2000. (Pubitemid 30102912)
13. Grossman D, McNiff JM, Li F and Altieri DC: Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 113: 1076-1081, 1999. (Pubitemid 30013356)
14. Grossman D, McNiff JM, Li F and Altieri DC: Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79: 1121-1126, 1999. (Pubitemid 29444543)
15. Humphrey PA: Urinary bladder pathology 2004: An update. Am Diagn Pathol 8: 380-389, 2004.
16. Cheng L, Montironi R, Davidson DD and Lopez-Beltran A: Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 22(Suppl 2): 70-95, 2009.
17. Shariat SF, Lotan Y, Saboorian H, Khoddami SM, Roehrborn CG, Slawin KM and Ashfaq R: Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer 100(4): 751-757, 2004. (Pubitemid 38176853)
18. Li F, Yang J, Ramnath N, Javle MM and Tan D: Nuclear or cytoplasmic expression of survivin: What is the significance? Int J Cancer 114: 509-512, 2005.
19. Mahotka C, Wenzel M, Springer E, Gabbert HE and Gerharz CD: Survivin-ΔEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59: 6097-6102, 1999. (Pubitemid 30035627)
20. Badran A, Yoshida A, Ishikawa K, Goi T, Yamaguchi A, Ueda T and Inuzuka M: Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem Biophys Res Commun 314: 902-907, 2004. (Pubitemid 38112885)
21. Caldas H, Honsey LE and Altura RA: Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies. Mol Cancer 4: 11, 2005. (Pubitemid 41460847)
22. Chen YB, Tu JJ, Kao J, Zhou XK and Chen YT: Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma. Arch Pathol Lab Med 132(2): 224-231, 2008. (Pubitemid 351213791)
23. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8): 917-921, 1997. (Pubitemid 27353455)
24. Ku JH, Kwak C, Lee HS et al: Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol 171: 631-635, 2004. (Pubitemid 38090445)
25. Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI and Shariat SF: Survivin expression in patients with non-muscle invasive urothelial cell carcinoma of the bladder. Urology 70(3): 482-486, 2007. (Pubitemid 47464512)
26. Lehner R, Lucia MS, Jarboe EA et al: Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 10: 134-138, 2002. (Pubitemid 34553169)
27. Shariat SF, Ashfaq R and Karakiewicz PI: Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer 109: 1106-1113, 2007. (Pubitemid 46435389)
28. Swana HS, Grossman D, Anthony JN et al: Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341: 452-453, 1999. (Pubitemid 29362524)